Non-Invasive Prenatal Testing Market Analysis, By Service, Size, Share, Growth, Segment, Trends and Forecast 2029
Non-Invasive Prenatal Testing Market The research report is designed with a nice combination of industry insights, smart solutions, practical solutions, and latest technologies to provide better user experience. Under market segmentation, research and analysis is performed on the basis of several market and industry segments such as application, vertical, deployment model, end user, and geography. To execute this market research, proficient and advanced tools and techniques have been used including SWOT analysis and Porter’s five forces analysis. Businesses can surely foresee reduced risk and failures with this market report.
After introducing next-generation sequencing technology, it is now possible to sequence fetal DNA fragments that can be integrated into a complete genetic map, allowing the fetal genome to be inspected prenatally and non-invasively. New approaches to screening for fetal chromosomal aneuploidies have been developed through advances in molecular technologies and the identification of cell-free fetal DNA in maternal plasma.
Data Bridge Market Research analyzes that the Non-Invasive Prenatal Testing Market from USD 3.22 Billion in 2021 will reach USD 9.06 Billion by 2029 and is expected to grow at a CAGR of 13.80% during the forecast period 2022 to 2029. Along with market insights such as market value, growth rate, market segments, geographic coverage, market players and market scenario, market report organized by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, price analysis, and regulatory framework.
Non-invasive prenatal test Market dynamics
High risk of chromosomal abnormalities with increasing maternal age
A woman’s age at the time of childbirth is called her maternal age. Increasing maternal age can lead to a variety of health issues, including reduced fertility, high blood pressure, and an increased risk of miscarriage, stillbirth, and maternal death. In addition, due to defective chromosome division, maternal age can increase the incidence of genetic abnormalities in newborns. Microcephaly, a short neck, upward tilted eyes, weak muscle tone, and heart, bowel, and breathing difficulties are all possible outcomes in newborns. These data imply that there has been an increase in advanced maternal age globally, which is likely to lead to more health problems. Thus, the increasing maternal age, coupled with the increasing incidence of chromosomal abnormalities, is expected to drive the demand for NIPT testing.
Increasing incidence of chromosomal abnormalities
The increasing frequency of chromosomal abnormalities, along with the increased use of the products in new applications, is driving the organic revenue growth of the market. Also, innovations in existing tests in terms of extended functionality, improved chemistry, and bioinformatics analysis are expected to drive the market growth. Improved payment policies for ordinary and low-risk pregnancies are one of the major market drivers. Natera announced in December 2020 that its non-invasive prenatal test (NIPT) would be covered for all pregnancies by Aetna, the leading US health insurer.
High incidence rate of Down syndrome
One of the major factors driving the non-invasive prenatal testing (NIPT) market is the increase in the average age of mothers, which has raised concerns about the safety of the fetus. Down syndrome is a chromosomal disorder in which an extra chromosome 21 is formed as a result of an error in cell division, and it can damage the cognitive abilities and physical growth of the fetus. NIPT screening tests are safe for mother and baby, pose no risk of miscarriage, and can detect over 99% of Down syndrome cases. According to the National Down Syndrome Society and the Centers for Disease Control and Prevention, one in 700 babies in the United States is born with Down syndrome, and 80% of children with Down syndrome are born to older mothers. The increased risk of having babies with Down syndrome in older women is driving the non-invasive prenatal testing market.
NIPT can be used to detect chromosomal abnormalities such as Down syndrome, trisomy 18 and 13, as well as excess or missing X or Y chromosomes. The likelihood of a genetic disease in the fetus is determined by non-invasive prenatal examinations. The non-invasive prenatal testing market is driven by an increase in the number of children with chromosomal disorders and improved diagnostic imaging technology. The growing insurance coverage for medium and low risk pregnancies is also expected to benefit the non-invasive prenatal testing market.
Scope of the Global Non-Invasive Prenatal Testing Market
The non-invasive prenatal testing market is segmented on the basis of product, method, application, type of test, technology, and end user. The growth among these segments will help you analyze weak growth segments in the industries and provide users with valuable market insight and market insights to help them make strategic decisions to identify major applications of the market.
Assay kits and reagents
Biochemical screening tests
Cell-Free DNA in Maternal Plasma Tests
Type of test
Get details of report table of contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-non-invasive-prenatal-testing-market
Competitive landscape and non-invasive prenatal screening Market share analysis
Non-Invasive Prenatal Testing Market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, research and development investment, new market initiatives, global presence, locations and production facilities, production capacities, company strengths and weaknesses, product launch, product breadth and breadth, application dominance. The data points provided above are only related to the companies’ focus on the non-invasive prenatal testing market.
Some of the major players operating in the non-invasive prenatal testing market are:
Illumina, Inc. (USA)
Thermo Fisher Scientific Inc. (USA)
General Electric (USA)
BGI Group (China)
Agilent Technologies, Inc. (USA)
F. Hoffmann-La Roche SA (Switzerland)
PerkinElmer Inc. (USA)
Laboratory Corporation of America Holdings (USA)
Natera, Inc. (USA)
Yourgene Health (USA)
Eurofins LifeCodexx GmbH (Germany)
Quest Diagnostics Incorporated (USA)
Myriad Genetics Inc. (USA)
NIPD Genetics (Cyprus)
Next Biosciences (South Africa)
Regions covered in the research report:
Middle East and Africa (GCC countries and Egypt)
North America (United States, Mexico and Canada)
South America (Brazil, etc.)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)
Browse In-Depth Research Report @ https://www.databridgemarketresearch.com/reports/global-non-invasive-prenatal-testing-market
Top Trending Reports:-
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and consulting company with an unparalleled level of sustainability and advanced approaches. We are committed to uncovering the best consumer insights and fostering useful insights for your business to succeed in the marketplace.
Data Bridge Market Research is the result of pure wisdom and practice that was conceived and incorporated in Pune in 2015. The company came into existence from the health department with far fewer employees having the intent to cover the entire market while providing best in class analysis. . Later, the company expanded its departments, as well as its reach by opening a new office in Gurugram in 2018, where a team of highly qualified personnel join hands for the growth of the company. “Even in the difficult times of COVID-19 where the virus has slowed down everything globally, the dedicated team at Data Bridge Market Research has been working around the clock to provide quality and support to our client base, which is also a testament to the excellence of our sleeve.”
Data Bridge Market Research
USA: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475